Fabrication of a Corneal Epithelial Cell Sheet from Human Pluripotent Stem Cells by a Method Based on Spontaneous Ocular Cell Differentiation

doi:10.1038/protex.2016.009

Method Article

Fabrication of a Corneal Epithelial Cell Sheet from Human Pluripotent Stem Cells by a Method Based on Spontaneous Ocular Cell Differentiation

https://doi.org/10.1038/protex.2016.009

This work is licensed under a CC BY-NC 3.0 License

This protocol has been posted on Protocol Exchange, an open repository of community-contributed protocols sponsored by Nature Portfolio. These protocols are posted directly on the Protocol Exchange by authors and are made freely available to the scientific community for use and comment.

Version 1

posted 18 Feb, 2016

You are reading this latest protocol version

We have established a novel culture system to induce the formation of corneal epithelium through the spontaneous development of ocular cells from human induced pluripotent stem cells (hiPSCs). The hiPSC derived-corneal epithelial cells (hiCECs) can be purified by FACS with specific antibodies and have the ability to reconstruct functional corneal epithelium expressing p63, K12, and PAX6.

Biological techniques

iPS cells

ocular surface

corneal epithelium

The generation of functional ocular cells from human induced pluripotent cells (hiPSCs) would represent a major advance in our ability to understand eye development and discover new strategies for the treatment of ocular diseases. Recent works with pluripotent stem cells in culture have revealed a previously under-appreciated level of intrinsic cellular self-organization, with a focus on the retina and retinal cells^1-5. However, the method for the generation of functional corneal epithelial stem/progenitor cells hasn’t been established. Here, we demonstrate the generation of a self-formed ectodermal autonomous multi-zone (SEAM) of ocular cells, and the isolation of functional corneal epithelial stem/progenitor cells from hiPSCs. This culture method allows hiPSCs to spontaneously form multi-cellular zones, each composed of multiple ectodermal ocular cell lineages including corneal epithelial stem/progenitor cells.

hiPSC (201B7; RIKEN Bio Resource Center, #HPS0063)

PE-conjugated CD104 (58BX4; Bio Legend, #327808)

FITC-conjugated SSEA-4 (MC813-70; BioLegend, #330410)

Alexa647-conjugated TRA-1-60 (TRA-1-60-R; BioLegend, #330606)

Anti-PAX6 antibody (PRB-278P; BioLegend, #901301)

Anti-p63 antibody (4A4; Santa Cruz Biotechnology, #sc-8431)

Anti-K12 antibody (N-16; Santa Cruz Biotechnology, #sc-17098)

Anti-MUC16 antibody (OV185:1; Abcam, #ab697)

StemFit^TM medium (Ajinomoto, AK02 or AK03)

Accutase^TM (Life Technologies, #A11105-01)

TrypLE^TM select (Life Technologies, #12563-029)

0.5 mM EDTA solution (Nacalai tesque, #13567-84)

KGF (R&D, #251-KG or Wako, #112-00813)

Y-27632 (Wako, #034-24024)

B-27 supplement (Life Technologies, #17504-044)

LN511E8 fragment (i-Matrix-511; Nippi, #892011)

GMEM (Life Technologies, #11710-035)

Penicillin-Streptomycin solution (Life Technologies, #15140-122)

Non-essential amino acids (Life Technologies, #11140-050)

Sodium pyruvate (Life Technologies, #11360-070)

Knockout serum replacement (KSR) (Life Technologies, #10828-028)

2-mercaptoethanol (2ME) (Life Technologies, #21985-023)

Monothioglycerol (replacement for 2ME) (Wako, #195-15791)

CnT-PR [w/o; EGF and FGF2] (CELLnTEC, #CnT-PR-EF)

DMEM/F12 [1:1] (Life Technologies, #11320-033)

DMEM without glutamine and Nutrient Mixture F-12 Ham (3:1) (Life Technologies, #10313-021, #11765-054)

Hydrocortisone succinate (Wako, #080-05581)

3,3',5-Triiodo-L-thyronine sodium salt (MP Biomedicals, #194585)

Cholera toxin (List Biological Laboratory, #100B)

Bovine transferrin HOLO form (Life Technologies, #11107-018)

L-glutamine (Life Technologies, #25030-081)

Insulin transferrin selenium solution (Life Technologies, #41400-045)

FBS (Japan Bio Serum, #15-001-JBS or Life Technologies, #12483-020)

Equipment

FACSAriaII (BD Biosciences)

CO₂ Incubator (Panasonic)

Bio-clean bench (Panasonic)

Microscope (Axiovert D1, Carl Zeiss)

Centrifuge machine (TOMY, #LC-230)

Culture plate 6-well, 12-well (Corning, #353046, #353043)

Culture insert 12-well (FALCON, #353180)

UpCell^® 6-well plate (Cell Seed, #CS3004)

STEMFULL^TM tube (Sumitomo Bakelite, #MS-90150)

Cell Strainer (40 µm) (Corning, #352340)

Countess^® (Thermo Fisher Scientific)

PVDF membrane filter (Millipore, #SVWG04700)

Cell Scraper (Sumitomo Bakelite, #MS-93100)

Preparation of culture medium

Differentiation medium (DM)⁶:

GMEM supplemented with 10% knockout serum replacement (KSR), 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 2 mM L-glutamine, 1% Penicillin-Streptomycin solution, and 55 µM 2-mercaptoethanol (2ME) or Monothioglycerol (replacement for 2ME).

Corneal differentiation medium (CDM)

DM and CnT-PR [w/o; EGF and FGF2] (1:1) containing 20 ng/ml KGF, 10 µM Y-27632, and 1% Penicillin-Streptomycin solution.

Corneal epithelium maintenance medium (CEM)

DMEM/F12 [1:1] containing 2% B-27 supplement, 20 ng/ml KGF, and 10 µM Y-27632, 1% Penicillin-Streptomycin solution.

KCM medium

DMEM without glutamine and Nutrient Mixture F-12 Ham (3:1) supplemented with 5% FBS, 0.4 µg/ml hydrocortisone succinate, 2 nM 3,3',5-Triiodo-L-thyronine sodium salt, 1 nM cholera toxin, 2.25 µg /ml bovine transferrin HOLO form, 2 mM L-glutamine, 0.5% insulin transferrin selenium solution, and 1% Penicillin-Streptomycin solution.

Corneal epithelium-maturation medium (CMM)

KCM medium containing 20 ng/ml KGF and 10 µM Y-27632.

hiPSC clone

The use of an appropriate hiPSC clone is important to achieve ocular surface epithelial cell differentiation, and in our hands hiPSC clone 201B7 was found to be suitable.

hiPSC maintenance and subculture

The hiPSCs (201B7) are cultured in StemFit^TM medium on LN511E8-coated 6-well culture plates.

Plate coating

Coat new 6-well culture plates with LN511E8 at 0.5 µg/cm² in 1.5 ml PBS by incubation at 37°C for at least 60 min.
Add 0.7 ml StemFit^TM medium to the culture plates.
Remove the mixed solution.
Immediately add 1.5 ml StemFit^TM medium containing 10 µM Y-27632 and incubate at 37°C in 5% CO₂. Cell passaging
Remove the medium.
Wash hiPSCs once with 1 ml PBS.
Add 300 µl dissociation solution (50% TrypLE select and 50% 0.5 mM EDTA solution) and incubate for 4-5 min at 37°C.
Remove the dissociation solution carefully (hiPSCs are still attached to the culture plates at this point).
Wash the hiPSCs once with 2 ml PBS, and then add 1 ml StemFit™ medium containing 10 µM Y-27632.
Harvest the hiPSCs with a Cell Scraper.
Pipette the hiPSCs about 10 times with a 200 or 1000µL micropipette and then harvest the dissociated hiPSCs in a 1.5 ml tube.
Count the collected hiPSCs using a Countess^® Machine after staining with Trypan blue (settings for Countess^®; Sensitivity: 5, Minimium size: 8, Maximum size: 30, Circularity: 75).
Seed hiPSCs on LN511E8 coated 6-well culture plates at 13,000 cells/well.
Incubate the plates at 37°C in 5% CO₂.
The next day, change the medium to fresh StemFit^TM medium without Y-27632 and incubate at 37°C in 5% CO₂ up to day seven. The medium change should be performed every two days. Critical; If hiPSCs are maintained in other conditions -- such as under co-cultivation with MEF feeder layers or in other feeder-less culture systems --, after removal of the feeder cells, dissociated hiPSCs must be seeded in the StemFit^TM/LN511E8 culture system at 13,000 cells/well and be passaged at least five times for adaptation to the conditions.

Differentiation culture

Preparing hiPSCs for differentiation (Day -10)

Coat a 6-well or 12-well culture plate with LN511E8 at 0.5 µg/cm² according to the previously indicated method.
Harvest hiPSCs by the same method used for hiPSC passaging.
Seed dissociated hiPSCs on 6-well plates at 3000-6000 cells/well, or on 12-well plates at 1000-2000 cells/well in 1.5 ml (6-well plate) or 0.6 ml (12-well plate) of StemFit^TM medium containing 10 µM Y-27632.
Incubate the plates at 37°C in 5% CO₂.
The next day, change the medium to fresh StemFit^TM medium without Y-27632.
Incubate the plates at 37°C in 5% CO₂ for 10 days in total. The medium change should be performed every two days before day seven, and every day thereafter.

Ocular cell differentiation culture (Day 0-)

After 10 days culture in StemFit^TM medium, change the medium to 2 ml (6-well plate) of DM (Day 0).
Incubate the plates at 37°C in 5% CO₂ for four weeks, changing the medium every 2-3 days (three times per week). At around three weeks, hiPSC colonies appear as multi-cellular colonies formed of 3-4 concentric zones (this is called a “SEAM”; Self-formed Ectodermal Autonomous Multi-zone). Cells in the third zone from the centre of the colony are ocular surface ectodermal cells, which will differentiate into corneal epithelial cells.

CDM culture (Day 28-)

After four weeks of incubation in DM, change the medium to 2 ml (6-well plate) of CDM.
Incubate the plates for an additional four weeks at 37°C in 5% CO₂ (i.e. eight weeks in total). The medium should be changed every 2-3 days (three times per week). Optional; to promote retinal cell differentiation, the medium can be changed to CEM at day 28. After incubation in CEM for an additional 2-3 weeks (i.e. 6-7 weeks in total), pigmented RPE cells are frequently observed.

Manual pipetting to remove non-epithelial cells (Day 49-)

On the way to CDM culture, manual pipetting should be performed to remove non-epithelial cells such as neuronal cells, retinal cells and/or lens cells. The yield of corneal epithelial cells on subsequent cell sorting is higher than it would be without manual pipetting.

At around three weeks of incubation in CDM (i.e. after seven weeks in total), perform manual pipetting using PIPETMAN^TM (1000 or 200 µl) on a clean bench.
After pipetting, change the medium containing the detached cells to fresh CDM.
Incubate the plates for an additional one week in CDM (i.e. eight weeks in total).

CEM culture (Day 56-)

After CDM culture for four weeks (i.e. eight weeks overall) change the medium to 2 ml (6-well plate) of CEM.
Incubate the plates for at least two weeks (i.e. 10 weeks in total) to a maximum of eight weeks (i.e. 16 weeks in total) at 37°C in 5% CO₂. The medium should be changed every 2-3 days (three times per week).

FACS for isolating corneal epithelial stem/progenitor cells (Day 70-)

After CEM culture, wash the hiPSCs once with PBS.
Add Accutase^TM to the differentiated hiPSCs and incubate for 45 min at 37°C.
Perform pipetting several times and again incubate for 15 min at 37°C.
Collect and re-suspend the dissociated cells in ice-cold KCM medium in a STEMFULL^TM 15 ml tube.
Filter the cells using a Cell Strainer (40 µm) and count the cell number.
Centrifuge the cells at 1200 rpm for 8 min.
Aspirate the supernatant and re-suspend the cells in ice-cold KCM containing FITC-conjugated SSEA-4 (MC813-70), PE-conjugated CD104 (ITGB4; 58BX4) and Alexa647-conjugated TRA-1-60 (TRA-1-60R) antibodies.
Incubate the cells for 1 hr at 4°C (agitate the cells every 20 min).
Wash the cells twice with PBS.
Resuspend the cells in PBS by filtration using a Cell strainer (40 µm). Cells should be stained with non-specific isotype IgG (for SSEA-4 and CD104) or IgM (for TRA-1-60) as controls. For each fluorescent probe, single-color stained cells should be prepared for color compensation during flow cytometry.
Set up the FACSAriaII machine.
Subject stained cells to sorting in the FACSAriaII.
Perform compensation between the detectors for FITC, PE, and Alexa647 using each of the single stained cells.
Analyze the triple color-stained cells.
Sort the SSEA-4+, CD104+, and TRA-1-60- population (i.e. the hiCEC fraction) to 8 ml of KCM in a STEMFULL^TM 15 ml tube. Typically, in TRA-1-60 negative cells, 5-20% of the cells are detected as the hiCEC fraction.
Collect the hiCECs by centrifugation at 1200 rpm for 8 min.
Re-suspend the cells in CEM on ice.

Fabrication of hiCEC sheet (Day 70-)

Coat a 6-well UpCell^® plate (for corneal epithelial transplantation) or a 12-well culture insert (for promoting differentiation or for long-term culture) with LN511E8 at 0.5-1.0 mg/cm² by incubation at 37°C for at least 60 min.
Seed FACS-sorted SSEA-4+, CD104+, TRA-1-60- cells (hiCECs) on the 6-well UpCell^® plate at 1.5-6.0 x 10⁵ cells/well or on the 12-well culture inserts at 0.5-1.0 x 10⁵ cells/well in CEM.
Incubate the plates at 37°C in 5% in CO₂ for 5-12 days until confluence. The medium should be changed every two days.

UpCell^® culture and cell harvest

After reaching confluence, change the medium to CMM.
Incubate the cells in CMM for 3-10 days at 37°C in 5% CO₂ to allow stratification. The medium should be changed every two days.
Incubate the UpCell^® plate at 20°C for 30 min.
Place the PVDF membrane on the cell sheet as a carrier⁷.
Harvest the cell sheet using tweezers.

Insert culture (for long-term culture or for promoting maturation)

36’. For long-term culture, continue to incubate the cells in CEM. These cells can be maintained for at least 10 weeks in our hands.

37’. To promote the maturation of cells, change the medium to CMM and incubate for an additional 3-10 days.

The entire protocol from the seeding of hiPSCs to the fabrication of corneal epithelial cell sheets takes a total of 94 days minimum.

Cells do not differentiate to corneal epithelial cells

For a first trial we recommend the use of 201B7 hiPSCs. The differentiation efficiency varies among different hiPS clones.

If hiPSCs are maintained in other conditions -- such as under co-cultivation with MEF feeder layers or in other feeder-less culture systems -- the hiPSCs must be passaged in the StemFit^TM/LN511E8 culture system at least five times for adaptation to the conditions.

Multi-zonal colony formation

By four weeks of differentiation, colonies with concentric multi-cellular zones (typically 3-4 zones) will have been generated spontaneously. For the validation of ocular surface epithelial induction, PAX6 and p63-double staining is useful. When double positive cells are detected at 3-4 weeks (peripheral region of the colony (i.e. in zone-3)) and at 10 weeks (overall), the method is deemed to have worked successfully.

Fabrication of corneal epithelial cell sheet

FACS-sorted hiCECs typically exhibit a small cobblestone-like morphology by phase contrast microscopy, and when observed by H&E staining are found to be stratified into 2-4 layers after two weeks of culture in CEM and CMM.

The stratified cell sheet typically expresses K12 and PAX6 throughout all cell layers, as well as MUC16 (on the sheet’s surface) and p63 (strongly in the basal region). These are corneal epithelial specific markers.

1 Eiraku, M. et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472, 51-56, doi:10.1038/nature09941 (2011).

2 Nakano, T. et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell stem cell 10, 771-785, doi:10.1016/j.stem.2012.05.009 (2012).

3 Zhong, X. et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nature communications 5 (2014).

4 Reichman, S. et al. From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium. Proceedings of the National Academy of Sciences of the United States of America 111, 8518-8523, doi:10.1073/pnas.1324212111 (2014).

5 Mellough, C. B. et al. IGF‐1 Signaling Plays an Important Role in the Formation of Three‐Dimensional Laminated Neural Retina and Other Ocular Structures from Human Embryonic Stem Cells. Stem cells (2015).

6 Kawasaki, H. et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28, 31-40 (2000).

7 Nishida, K. et al. Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation 77, 379-385, doi:10.1097/01.TP.0000110320.45678.30 (2004).

This work was supported in part by the project for the realization of regenerative medicine of The Japan Agency for Medical Research and Development (AMED), The Japan Science and Technology Agency (JST) and The Ministry of Health, Labour, and Welfare of Japan and the Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan.

The authors declare no competing financial interests.

PDF

Version 1

posted 18 Feb, 2016

You are reading this latest protocol version

Fabrication of a Corneal Epithelial Cell Sheet from Human Pluripotent Stem Cells by a Method Based on Spontaneous Ocular Cell Differentiation

Status:

Version 1

Abstract

Introduction

Reagents

Equipment

Procedure

Timing

Troubleshooting

Anticipated Results

References

Acknowledgements

Competing Interests

Status:

Version 1

Privacy Policy

Terms of Service